Article: Amprenavir

Systematic (IUPAC) name
tetrahydrofuran-3-yl [3-[(4-aminophenyl)sulfonyl- (2-methylpropyl) amino] -1-benzyl-2- hydroxy-propyl] aminomethanoate
CAS number 161814-49-9
ATC code J05AE05
PubChem 65016
DrugBank APRD00605
Chemical data
Formula C25H35N3O6S
Mol. weight 505.628 g/mol
Pharmacokinetic data
Bioavailability  ?
Protein binding 90%
Metabolism  ?
Half life 7.1-10.6 hours
Excretion  ?
Therapeutic considerations
Pregnancy cat.


Legal status
Routes  ?

Amprenavir (Agenerase®) is a protease inhibitor used to treat HIV. It was approved by the Food and Drug Administration on April 15, 1999, for twice-a-day dosing instead of needing to be taken every eight hours. The convenient dosing came at a price, as the dose required is 1,200mg, delivered in eight very large gel capsules. Production of amprenavir was discontinued by the manufacturer December 31, 2004.

Retrieved from ""